1-(6-Bromo-1h-indol-3-yl)ethan-1-one, 95%, 250mg

GC-Kapillarsäule ROTI®Cap-1701, L 30 m, Ø-Innen 0,25 mm, Filmd. 0,50 µm, 1 Stück

N2-(3-METHOXYPHENYL)-N4-((TETRAHYDROFURAN-2-YL)METHYL)QUINAZOLINE-2,4-DIAMINE, 95%, 25mg

4-(Aminomethyl)bicyclo[2.2.2]octan-1-ol;hydrochloride, 98%, 5g

2-Amino-5-methylthiazole-4-carbaldehyde, 95.0%, 100mg

N-[4-[(4-propan-2-yloxyphenyl)methyl]phenyl]-4,5-dihydro-1H-imidazol-2-amine, 97%, 50mg

Fmoc-Leu-OH, 98%, 10g

1,3-Diallylurea, 95%, 5g

N-(3-Chlorophenyl)-2-((2-hydroxyethyl)amino)acetamide, 95.0%, 5g

(1-(METHYLSULFONYL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER, 95.0%, 100mg

2-(4-Amino-phenyl)-5-methyl-2,4-dihydro-pyrazol-3-one dihydrochloride, 95.0%, 250mg

3-(3,4-DIFLUOROPHENYL)-1,2-OXAZOL-5-AMINE, 95.0%, 500mg

1-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)cyclopentanecarboxylic acid, 98%, 1g